Longboard Pharmaceuticals, Inc. (LBPH)
|Net Income (ttm)||-1.40M|
Longboard Pharmaceuticals, a phase 1 biotech formed by Arena Pharmaceuticals developing medicines for neurological diseases, filed on Friday with the SEC to raise up to $86 million in an initi...
Longboard Pharmaceuticals, Inc. has filed to go public with an IPO on the NASDAQ.
Longboard Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases. We were formed in January 2020 by Arena Pharmaceuticals, Inc. (Arena) to advance a portfolio of centrally acting product candidates designed to be highly selective for specific G protein-coupled receptors (GPCRs). Our small molecule product candidates were discovered out of the same platform at Arena that represents a culmination of more than 20 years of GPCR research. We are developing LP352,... [Read more...]
|IPO Date |
Kevin R. Lind
|Stock Exchange |
|Ticker Symbol |